Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 9, Number 7—July 2003
Research

Acute Flaccid Paralysis and West Nile Virus Infection

James J. Sejvar*Comments to Author , A. Arturo Leis†, Dobrivoje S. Stokic†, Jay A. Van Gerpen‡, Anthony A. Marfin*, Risa Webb§, Maryam B. Haddad*, Bruce C. Tierney*, Sally A. Slavinski§, Jo Lynn Polk†, Victor Dostrow†, Michael Winkelmann†, and Lyle R. Petersen*
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †Methodist Rehabilitation Center, Jackson, Mississippi, USA; ‡Ochsner Clinic, New Orleans, Louisiana, USA; §Mississippi State Department of Health, Jackson, Mississippi, USA

Main Article

Table 3

Initial laboratory findings in patients with acute flaccid paralysis associated with acute West Nile virus infectiona

Case no. Leukocytes
(x103/mm3) Hematocrit (%) CSF
WBC (/mm3) CSF
RBC (/mm3) CSF
protein (mg/dL) CSF
glucose (mg/dL)
1
 17.6
 38.0
 3
 1,778
 89
 54
2
 3.6
 38.2
 2,600
 87
 204
 99
3
 11.8
 44.4
 140
 40
 234
 74
4
 9.5
 37.8
 143
 4
 116
 119
5
 7.9
 45.6
 Not performed
 Not performed
 Not performed
 Not performed
6
 13.0
 45.4
 329
 7
 75
 66
7 10.3 Not performed 182 9 37 79

aCSF, cerebrospinal fluid; WBC, leukocyte count; RBC, erythrocyte count.

Main Article

Page created: December 22, 2010
Page updated: December 22, 2010
Page reviewed: December 22, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external